Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Guselkumab”

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT00508547
What this trial is testing

Psoriasis Longitudinal Assessment and Registry

Who this might be right for
Psoriasis
Janssen Scientific Affairs, LLC 20,167
Testing effectiveness (Phase 2)Active Not RecruitingNCT05242471
What this trial is testing

Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Janssen Research & Development, LLC 703
Early research (Phase 1)Ended earlyNCT05083078
What this trial is testing

Guselkumab and Risankizumab in Healthy Participants and Participants With Psoriatic Arthritis

Who this might be right for
Arthritis, PsoriaticHealthy
Janssen Research & Development, LLC 11
Large-scale testing (Phase 3)Study completedNCT02641730
What this trial is testing

An Efficacy and Safety of Guselkumab in Participants With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
Janssen Pharmaceutical K.K. 159
Post-approval studies (Phase 4)Looking for participantsNCT07616687
What this trial is testing

Optimal Care With Guselkumab in Crohn's Disease / OPTIM Study A Prospective Open Label Interventional, Multicenter Study

Who this might be right for
Crohn Disease (CD)Intensification
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives 210
Testing effectiveness (Phase 2)Study completedNCT03628924
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS)

Who this might be right for
Hidradenitis Suppurativa
Janssen Research & Development, LLC 184
Not applicableLooking for participantsNCT07582783
What this trial is testing

Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 200
Large-scale testing (Phase 3)Study completedNCT05083182
What this trial is testing

Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis

Who this might be right for
Arthritis, Juvenile
Janssen Research & Development, LLC 48
Large-scale testing (Phase 3)Active Not RecruitingNCT03466411
What this trial is testing

The Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Janssen Research & Development, LLC 1,409
Not applicableNot Yet RecruitingNCT07822529
What this trial is testing

Long Term Persistency of Guselkumab in Adult Participants With Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel Diseases
Janssen Research & Development, LLC 400
Not applicableLooking for participantsNCT07166315
What this trial is testing

Treatment Effectiveness in People With axSpA or PsA Starting Treatment With Bimekizumab, Risankizumab, Guselkumab, Upadacitinib, or a TNF Inhibitor

Who this might be right for
Axial Spondylarthritis (axSpA)Psoriatic Arthritis (PsA)
Adelphi Real World 700
Not applicableNo Longer AvailableNCT04948398
What this trial is testing

Post-Trial Access for Guselkumab in Participants With Familial Adenomatous Polyposis

Who this might be right for
Adenomatous Polyposis Coli
Janssen Research & Development, LLC
Not applicableLooking for participantsNCT07246460
What this trial is testing

Ultrasound and Proteomics for Guselkumab Response Assessment in Crohn's Disease (UPGRADE).

Who this might be right for
Crohn's Disease of Both Small and Large Intestine
University of Calgary 90
Testing effectiveness (Phase 2)Study completedNCT04683029
What this trial is testing

Guselkumab in Participants With Systemic Sclerosis

Who this might be right for
Scleroderma, Systemic
Janssen Pharmaceutical K.K. 56
Large-scale testing (Phase 3)Study completedNCT02325219
What this trial is testing

An Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Janssen Pharmaceutical K.K. 192
Very early researchWithdrawnNCT04084665
What this trial is testing

Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab.

Who this might be right for
Hidradenitis Suppurativa
Rockefeller University
Large-scale testing (Phase 3)Study completedNCT02905331
What this trial is testing

Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 78
Not applicableWithdrawnNCT07255781
What this trial is testing

Shared Pathways Between Non-Alcoholic Fatty Liver Disease and Psoriatic Disease With Guselekumab Therapy

Who this might be right for
Psoriasis (PsO)PsA (Psoriatic Arthritis)NAFLD (Nonalcoholic Fatty Liver Disease)
University of California, San Diego
Large-scale testing (Phase 3)Looking for participantsNCT07499232
What this trial is testing

Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 530
Not applicableLooking for participantsNCT07532486
What this trial is testing

Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese Participants of Moderate-to-severe Plaque Psoriasis

Who this might be right for
Psoriasis
Second Affiliated Hospital, Zhejiang University, School of Medicine 400
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation